Lis Stilgren

1.7k total citations · 1 hit paper
25 papers, 1.3k citations indexed

About

Lis Stilgren is a scholar working on Molecular Biology, Orthopedics and Sports Medicine and Oncology. According to data from OpenAlex, Lis Stilgren has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Orthopedics and Sports Medicine and 8 papers in Oncology. Recurrent topics in Lis Stilgren's work include Bone health and treatments (8 papers), Bone health and osteoporosis research (8 papers) and Bone Metabolism and Diseases (7 papers). Lis Stilgren is often cited by papers focused on Bone health and treatments (8 papers), Bone health and osteoporosis research (8 papers) and Bone Metabolism and Diseases (7 papers). Lis Stilgren collaborates with scholars based in Denmark, United States and Norway. Lis Stilgren's co-authors include Charlotte Landbo Tofteng, Bo Abrahamsen, Pia Eiken, Jens‐Erik Beck Jensen, L Mosekilde, Lars Rejnmark, Louise Lind Schierbeck, Lars Køber, Leif Mosekilde and Jonna Skov Madsen and has published in prestigious journals such as Circulation, International Journal of Molecular Sciences and BMJ.

In The Last Decade

Lis Stilgren

23 papers receiving 1.2k citations

Hit Papers

Effect of hormone replacement therapy on cardiovascular e... 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial
    2012 473 citations Louise Lind Schierbeck, Lars Rejnmark et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lis Stilgren Denmark 17 511 476 371 282 266 25 1.3k
Charlotte Landbo Tofteng Denmark 15 501 1.0× 482 1.0× 337 0.9× 212 0.8× 178 0.7× 24 1.4k
Janez Preželj Slovenia 24 461 0.9× 186 0.4× 501 1.4× 732 2.6× 378 1.4× 67 1.7k
Raja Padidela United Kingdom 22 525 1.0× 292 0.6× 122 0.3× 243 0.9× 239 0.9× 82 1.5k
J.C. Souberbielle France 19 328 0.6× 224 0.5× 150 0.4× 185 0.7× 156 0.6× 44 1.3k
G. Leb Austria 19 231 0.5× 161 0.3× 357 1.0× 245 0.9× 253 1.0× 53 1.1k
Marja Komulainen Finland 19 298 0.6× 347 0.7× 577 1.6× 235 0.8× 164 0.6× 32 1.1k
K.F. Gangar United Kingdom 13 804 1.6× 643 1.4× 166 0.4× 77 0.3× 118 0.4× 22 1.4k
Federico Hawkins Spain 28 817 1.6× 208 0.4× 784 2.1× 549 1.9× 581 2.2× 84 2.1k
A W Kung Hong Kong 24 338 0.7× 345 0.7× 1.1k 3.1× 536 1.9× 582 2.2× 44 2.2k
P. Clifton‐Bligh Australia 21 330 0.6× 160 0.3× 142 0.4× 201 0.7× 227 0.9× 54 1.1k

Countries citing papers authored by Lis Stilgren

Since Specialization
Citations

This map shows the geographic impact of Lis Stilgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lis Stilgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lis Stilgren more than expected).

Fields of papers citing papers by Lis Stilgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lis Stilgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lis Stilgren. The network helps show where Lis Stilgren may publish in the future.

Co-authorship network of co-authors of Lis Stilgren

This figure shows the co-authorship network connecting the top 25 collaborators of Lis Stilgren. A scholar is included among the top collaborators of Lis Stilgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lis Stilgren. Lis Stilgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gerke, Oke, Anders Rørbæk Madsen, Lis Stilgren, et al.. (2023). Head-to-Head Comparison of Tc-99m-sestamibi SPECT/CT and C-11-L-Methionin PET/CT in Parathyroid Scanning Before Operation for Primary Hyperparathyroidism. Molecular Imaging and Biology. 25(4). 720–726. 4 indexed citations
3.
4.
Schierbeck, Louise Lind, Lars Rejnmark, Charlotte Landbo Tofteng, et al.. (2012). Vitamin D deficiency in postmenopausal, healthy women predicts increased cardiovascular events: a 16-year follow-up study. European Journal of Endocrinology. 167(4). 553–560. 40 indexed citations
5.
Schierbeck, Louise Lind, Lars Rejnmark, Charlotte Landbo Tofteng, et al.. (2012). Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 345(oct09 2). e6409–e6409. 473 indexed citations breakdown →
6.
Schierbeck, Louise Lind, Lars Rejnmark, Charlotte Landbo Tofteng, et al.. (2011). Abstract 11380: Hormone Replacement Treatment in Early Postmenopausal Women Reduces Cardiovascular Events - A Randomized Controlled Study. Circulation. 124. 1 indexed citations
7.
Reppe, Sjur, Lis Stilgren, Bo Abrahamsen, et al.. (2007). Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism. American Journal of Physiology-Endocrinology and Metabolism. 292(5). E1465–E1473. 37 indexed citations
8.
Reppe, Sjur, Lis Stilgren, Ole Kristoffer Olstad, et al.. (2006). Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism. Bone. 39(1). 189–198. 21 indexed citations
9.
Abrahamsen, Bo, Jonna Skov Madsen, Charlotte Landbo Tofteng, et al.. (2005). Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone. 36(3). 577–583. 51 indexed citations
10.
Abrahamsen, Bo, Jacob Hjelmborg, Paul J. Kostenuik, et al.. (2005). Circulating amounts of osteoprotegerin and RANK ligand: Genetic influence and relationship with BMD assessed in female twins. Bone. 36(4). 727–735. 36 indexed citations
11.
Stilgren, Lis, Bo Abrahamsen, Basem M. Abdallah, & Niklas Rye Jørgensen. (2005). [The cytokine system of bone tissue].. PubMed. 167(8). 874–8. 1 indexed citations
12.
13.
Abdallah, Basem M., et al.. (2004). Increased RANKL/OPG mRNA Ratio in Iliac Bone Biopsies From Women with Hip Fractures. Calcified Tissue International. 76(2). 90–97. 53 indexed citations
14.
Abrahamsen, Bo, et al.. (2003). Effects of the Natural and Artificial Menstrual Cycle on the Production of Osteoprotegerin and the Bone Resorptive Cytokines IL-1b and IL-6. Calcified Tissue International. 72(1). 18–23. 14 indexed citations
15.
Tofteng, Charlotte Landbo, Andreas Kindmark, Bo Abrahamsen, et al.. (2003). Polymorphisms in the CYP19 and AR Genes?Relation to Bone Mass and Longitudinal Bone Changes in Postmenopausal Women With or Without Hormone Replacement Therapy: The Danish Osteoporosis Prevention Study. Calcified Tissue International. 74(1). 25–34. 46 indexed citations
16.
Vestergaard, Peter, Anne Pernille Hermann, Lis Stilgren, et al.. (2003). Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure—a randomised controlled study. Maturitas. 46(2). 123–132. 47 indexed citations
17.
Abrahamsen, Bo, Charlotte Landbo Tofteng, O. Bärenholdt, et al.. (2003). Standardization of BMD T-Scores in the First Five Years After the Menopause. Journal of Clinical Densitometry. 6(2). 87–95. 3 indexed citations
18.
Madsen, Jonna Skov, Søren Risom Kristensen, Niels Anders Klitgaard, et al.. (2002). Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: A randomized controlled study. American Journal of Obstetrics and Gynecology. 187(1). 33–39. 55 indexed citations
19.
Mosekilde, L, Henning Beck‐Nielsen, Ole Helmer Sørensen, et al.. (2000). Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women — results of the Danish Osteoporosis Prevention Study. Maturitas. 36(3). 181–193. 108 indexed citations
20.
Lorenzen, Tove, Flemming Pociot, Lis Stilgren, et al.. (1998). Predictors of IDDM recurrence risk in offspring of Danish IDDM patients. Diabetologia. 41(6). 666–673. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charlotte Landbo Tofteng Breakdown of academic impact, for papers by Janez Preželj Breakdown of academic impact, for papers by Raja Padidela Breakdown of academic impact, for papers by J.C. Souberbielle Breakdown of academic impact, for papers by G. Leb Breakdown of academic impact, for papers by Marja Komulainen Breakdown of academic impact, for papers by K.F. Gangar Breakdown of academic impact, for papers by Federico Hawkins Breakdown of academic impact, for papers by A W Kung Breakdown of academic impact, for papers by P. Clifton‐Bligh
Rankless by CCL
2026